Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
Recruiting · NCT04721873 · Registry updated 2023-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients | Body Weight, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, nutritional disorder, obesity disorder, overnutrition, ulcerative colitis | Recruiting | Phase 2 | 2023-05-16 | NCT04721873 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of California, San Diego | 337 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California San Diego | La Jolla | United States | 39 |